Holding hands during a shot may ease the sting
NCT ID NCT07673757
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study tests whether having a companion hold the patient's hand during an intramuscular injection can lower pain. Sixty adults receiving a standard injection are randomly assigned to either receive this supportive hand-holding or not. Pain levels are measured right after the shot, and researchers also look at how fear of pain relates to the experience.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- supportive hand-holding (therapeutic touch)
- What this could lead to
- If effective, this simple, drug-free technique could offer a low-cost way to ease injection pain for many people.
- What could go wrong
- This is a small, early-stage study. The effect may be small or not generalizable to other settings or injections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
Sep 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being between 18 and 60 years of age, * Being literate, * Being able to complete the Fear of Pain Questionnaire (FPQ) without missing items, * Having no known allergy or contraindication to pheniramine hydrogen maleate, * Not having lower respiratory tract disease/asthma and not being in pregnancy or lactation period, * Having normal consciousness (adequate orientation and ability to follow commands), * Not having a severe mood disorder. Exclusion Criteria: * Incomplete completion of the questionnaire/scale during the study, * Having medical conditions that may affect pain perception, such as peripheral vascular disease, peripheral neuropathy, or diabetes.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Therapeutic adherence and compliance are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kilis 7 Aralık University, School of Health Services
Kilis, Kilis, 79000, Turkey (Türkiye)